Biobase Sweden AB closes second capitalization round at new evaluation of 25 million SEK
Biobase Sweden AB closes the second of three planned capitalization rounds of 4 million SEK at an evaluation of 25 million SEK pre-money. The round was oversubscribed.
Biobase Sweden AB has an ambitious plan to grow the business both regionally and globally. Sales in Sweden is growing, and the company plans to introduce its products to the European market during 2022. Presence in North America is planned for late 2022, followed by Asia in 2023.
Biobase Sweden AB is a company focusing exclusively on bio-based high performance functional fluids for the construction-, manufacturing-, process-, and lubricant industries. The products are also biodegradable and non-toxic and can contribute to less climate impact of many industrial activities.